The urgent need for new antibacterial agents

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 1939-1940

  Wise, Richard ^a   Blaser, Martin ^a   Carrs, Otto ^a   Cassell, Gail ^a   Fishman, Neil ^a   Guidos, Robert ^a   Levy, Stuart ^a   Powers, John ^a   Norrby, Ragnar ^a   Tillotson, Glenn ^a   Davies, Rick ^a   Projan, Steven ^a   Dawson, Mike ^a   Monnet, Dominique ^a   Keogh Brown, Marcus ^a   Hand, Kieran ^a   Garner, Sarah ^a   Findlay, David ^a   Morel, Chantal ^a   Bax, Richard ^a,b   Burke, Frances ^a,c   Chopra, Ian ^a,d   Czaplewski, Lloyd ^a,e   Finch, Roger ^a,f   Livermore, David ^a,g   Piddock, Laura J V ^a,h   White, Tony ^a   more..

^a 11 the Wharf   (United Kingdom)

^b TRANSCRIP PARTNERS LLP   (United Kingdom)

^c Eli Lilly ^*  (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Biota Europe Ltd   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BEVACIZUMAB;

ANTIBIOTIC RESISTANCE; ARTICLE; AWARENESS; CANCER SURVIVAL; CLINICAL PRACTICE; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG UTILIZATION; HUMAN; MEDICAL SOCIETY; NEOPLASM; RISK BENEFIT ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG INDUSTRY; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 80051686188     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr261     Document Type: Article

References (10)

1. Swann MM, Baxter KL, Field HI et al. Report of the Joint Committee on the Use of Antibiotics in Animal Husbandry and Veterinary Medicine. London: Her Majesty's Stationery Office, 1969.
2. House of Lords Select Committee on Science and Technology. Session 1997-1998. Seventh Report. Resistance to Antibiotics and other Antimicrobial Agents. London: Her Majesty's Stationery Office, 1998.
3. Boucher HW, Talbot GH, Bradley JS. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
4. ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react. http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=444 (19 April 2011, date last accessed).
5. World Health Organization. Antimicrobial resistance: no action today, no cure tomorrow. http://www.who.int/world-health-day/2011/en/index.html (19 April 2011, date last accessed).
6. The BSAC Working Party on The Urgent Need. Regenerating antibacterial drug discovery development. http://www.bsac.org.uk/Resources/BSAC/TUN%20Report.pdf (19 April 2011, date last accessed).
7. Livermore DM on behalf of the BSAC Working Party on The Urgent Need. Discovery research: the challenge of finding new antibiotics. J Antimicrob Chemother 2011; 66: 1941-4.
8. Finch RG on behalf of the BSAC Working Party on The Urgent Need. Regulatory opportunities to encourage technology solutions to antibacterial drug resistance. J Antimicrob Chemother 2011; 66: 1945-7.
9. White AR on behalf of the BSAC Working Party on The Urgent Need. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control. J Antimicrob Chemother 2011; 66: 1948-53.
10. Genentech. Avastin - Historical sales. http://www.gene.com/gene/about/ir/historical/product-sales/avastin.html (5 May 2011, date last accessed).